MEEDER ASSET MANAGEMENT INC - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 169 filers reported holding BRIDGEBIO PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.7%.

Quarter-by-quarter ownership
MEEDER ASSET MANAGEMENT INC ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2021$95,000
+13.1%
2,034
+46.9%
0.01%
+25.0%
Q2 2021$84,000
-54.6%
1,385
-54.1%
0.00%
-55.6%
Q1 2021$185,000
+140.3%
3,015
+46.9%
0.01%
+80.0%
Q3 2020$77,000
+35.1%
2,052
+21.0%
0.01%
+25.0%
Q2 2020$57,000
+2750.0%
1,696
+3100.0%
0.00%
Q1 2020$2,000530.00%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$100,609,51348.41%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$514,990,89915.50%
M28 Capital Management LP 304,700$5,051,9265.71%
Cormorant Asset Management, LP 4,557,414$75,5624.98%
Octagon Capital Advisors LP 1,338,160$22,186,6933.19%
Ikarian Capital, LLC 594,686$9,859,8942.24%
Affinity Asset Advisors, LLC 389,800$6,462,8842.13%
VIKING GLOBAL INVESTORS LP 26,620,991$441,376,0312.07%
Ikarian Capital, LLC 549,600$9,112,3682.07%
Affinity Asset Advisors, LLC 320,000$5,305,6001.75%
View complete list of BRIDGEBIO PHARMA INC shareholders